Coagulation tests are useful to screen for some bleeding disorders in those with a suggestive bleeding history but alone are poorly predictive in assessing risk of bleeding pre procedure. An abnormal coagulation screen does not necessarily increase the risk of bleeding and a normal coagulation screen does not rule out a bleeding disorder.
Indications for coagulation screens include:
- Before starting anticoagulation
- When investigating thrombocytopenia
- To look for a lupus anticoagulant
- Monitor anti-vitamin K anticoagulant (only request specific assay i.e. INR for warfarin)
- In the presence of a bleeding history
- Monitor severity of liver disease
- In patients with liver disease and high ASA grade pre surgery
A common cause of a prolonged APTT is the presence of an antibody which interferes with the assay. The commonest example is a lupus anticoagulant (LA). When a prolonged APTT is found, the lab will often automatically do further tests to try to work out the cause. The confirmatory test for a LA is the DRVVT. A LA is a type of anti-phospholipid antibody and is often not clinically significant but can be associated with anti-phospholipid syndrome (APS) and other autoimmune diseases. Anti-cardiolipin and anti-beta-2 glycoprotein-1 antibodies are also seen in patients with APS. Anti-phospholipid antibodies are detectable in up to 5% of the normal population and can be a transient phenomenon and therefore we may advise to repeat after three months to ensure resolution. However this is only indicated in patients with symptoms suggestive of APS (pregnancy morbidity, thrombosis, neurological symptoms, thrombocytopenia etc.). In asymptomatic patients where a LA has been picked up coincidentally, no further tests are indicated.